FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REPORT OF FOREIGN ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
June 12, 2002
Centerpulse Ltd.
----------------
(Translation of Registrant's Name Into English)
Andreasstrasse 15
8050 Zurich
Switzerland
-----------
(Address of Principal Executive Offices)
(Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F.)
Form 20-F X Form 40-F
------- ------
(Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the information
to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act
of 1934.)
Yes No X
------ -------
(If "Yes" is marked, indicate below the file number assigned to the registrant
in connection with Rule 12g3-2(b): 82- )
------------------
Centerpulse Ltd. is filing this Report on Form 6-K regarding the plan to sell
its cardiac and vascular divisions and to furnish the press release which was
made public on June 12, 2002, and is attached as Exhibit 99.1 to this Report on
Form 6-K.
Exhibit 99.1 News Release - Centerpulse to concentrate on core business
aspects and plans to sell Cardiac and Vascular
Divisions
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this Current Report to be signed on its behalf
by the undersigned, thereunto duly authorized.
CENTERPULSE LTD.
Date: June 12, 2002 /s/ David S. Wise
-----------------------------
David S. Wise
Authorized Representative
EXHIBIT INDEX
Exhibit 99.1 News Release - Centerpulse to concentrate on core business
aspects and plans to sell Cardiac and Vascular
Divisions